Relationship of day-to-day reproductive hormone levels to sleep in midlife women

Howard M. Kravitz, Imke Janssen, Nanette Santoro, Joyce T. Bromberger, Miriam Schocken, Susan A. Everson-Rose, Kelly Karavolos, Lynda H. Powell

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background: We analyzed data from a single menstrual cycle from 630 women, aged 43 to 53 years, in the Daily Hormone Study component of the Study of Women's Health Across the Nation to determine whether hormone levels are associated with trouble sleeping as women enter the menopausal transition. Methods: Women recorded whether they had trouble sleeping the previous night. Morning urine specimens were obtained for daily determinations of levels of luteinizing hormone, follicle-stimulating hormone, estradiol metabolites (ie, estrone conjugates), and the progesterone metabolite (pregnanediol glucuronide). Women were categorized as premenopausal or early perimenopausal by bleeding patterns. Results: Average adjusted odds of reporting trouble sleeping were 29% higher in perimenopausal than in premenopausal women. The highest percentages of women in both menopausal groups reported trouble sleeping in the beginning or at the end of their cycle. After controlling for covariates, pregnanediol glucuronide level was associated with increased trouble sleeping in perimenopausal women and follicle-stimulating hormone level was associated with increased trouble sleeping in premenopausal women. Mood and vasomotor symptoms were the strongest and most consistent cocontributors to trouble sleeping. Conclusion: In this community-based sample of middle aged women, the most trouble sleeping was observed at the beginning and end of the menstrual cycle.

Original languageEnglish (US)
Pages (from-to)2370-2376
Number of pages7
JournalArchives of Internal Medicine
Volume165
Issue number20
DOIs
StatePublished - Nov 14 2005

Fingerprint

Sleep
Hormones
Pregnanediol
Glucuronides
Follicle Stimulating Hormone
Menstrual Cycle
Estrone
Women's Health
Luteinizing Hormone
Progesterone
Estradiol
Urine
Hemorrhage

Cite this

Kravitz, H. M., Janssen, I., Santoro, N., Bromberger, J. T., Schocken, M., Everson-Rose, S. A., ... Powell, L. H. (2005). Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Archives of Internal Medicine, 165(20), 2370-2376. https://doi.org/10.1001/archinte.165.20.2370

Relationship of day-to-day reproductive hormone levels to sleep in midlife women. / Kravitz, Howard M.; Janssen, Imke; Santoro, Nanette; Bromberger, Joyce T.; Schocken, Miriam; Everson-Rose, Susan A.; Karavolos, Kelly; Powell, Lynda H.

In: Archives of Internal Medicine, Vol. 165, No. 20, 14.11.2005, p. 2370-2376.

Research output: Contribution to journalArticle

Kravitz, HM, Janssen, I, Santoro, N, Bromberger, JT, Schocken, M, Everson-Rose, SA, Karavolos, K & Powell, LH 2005, 'Relationship of day-to-day reproductive hormone levels to sleep in midlife women', Archives of Internal Medicine, vol. 165, no. 20, pp. 2370-2376. https://doi.org/10.1001/archinte.165.20.2370
Kravitz, Howard M. ; Janssen, Imke ; Santoro, Nanette ; Bromberger, Joyce T. ; Schocken, Miriam ; Everson-Rose, Susan A. ; Karavolos, Kelly ; Powell, Lynda H. / Relationship of day-to-day reproductive hormone levels to sleep in midlife women. In: Archives of Internal Medicine. 2005 ; Vol. 165, No. 20. pp. 2370-2376.
@article{8eddf14c511047d8ac0dec871cb2cd56,
title = "Relationship of day-to-day reproductive hormone levels to sleep in midlife women",
abstract = "Background: We analyzed data from a single menstrual cycle from 630 women, aged 43 to 53 years, in the Daily Hormone Study component of the Study of Women's Health Across the Nation to determine whether hormone levels are associated with trouble sleeping as women enter the menopausal transition. Methods: Women recorded whether they had trouble sleeping the previous night. Morning urine specimens were obtained for daily determinations of levels of luteinizing hormone, follicle-stimulating hormone, estradiol metabolites (ie, estrone conjugates), and the progesterone metabolite (pregnanediol glucuronide). Women were categorized as premenopausal or early perimenopausal by bleeding patterns. Results: Average adjusted odds of reporting trouble sleeping were 29{\%} higher in perimenopausal than in premenopausal women. The highest percentages of women in both menopausal groups reported trouble sleeping in the beginning or at the end of their cycle. After controlling for covariates, pregnanediol glucuronide level was associated with increased trouble sleeping in perimenopausal women and follicle-stimulating hormone level was associated with increased trouble sleeping in premenopausal women. Mood and vasomotor symptoms were the strongest and most consistent cocontributors to trouble sleeping. Conclusion: In this community-based sample of middle aged women, the most trouble sleeping was observed at the beginning and end of the menstrual cycle.",
author = "Kravitz, {Howard M.} and Imke Janssen and Nanette Santoro and Bromberger, {Joyce T.} and Miriam Schocken and Everson-Rose, {Susan A.} and Kelly Karavolos and Powell, {Lynda H.}",
year = "2005",
month = "11",
day = "14",
doi = "10.1001/archinte.165.20.2370",
language = "English (US)",
volume = "165",
pages = "2370--2376",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "20",

}

TY - JOUR

T1 - Relationship of day-to-day reproductive hormone levels to sleep in midlife women

AU - Kravitz, Howard M.

AU - Janssen, Imke

AU - Santoro, Nanette

AU - Bromberger, Joyce T.

AU - Schocken, Miriam

AU - Everson-Rose, Susan A.

AU - Karavolos, Kelly

AU - Powell, Lynda H.

PY - 2005/11/14

Y1 - 2005/11/14

N2 - Background: We analyzed data from a single menstrual cycle from 630 women, aged 43 to 53 years, in the Daily Hormone Study component of the Study of Women's Health Across the Nation to determine whether hormone levels are associated with trouble sleeping as women enter the menopausal transition. Methods: Women recorded whether they had trouble sleeping the previous night. Morning urine specimens were obtained for daily determinations of levels of luteinizing hormone, follicle-stimulating hormone, estradiol metabolites (ie, estrone conjugates), and the progesterone metabolite (pregnanediol glucuronide). Women were categorized as premenopausal or early perimenopausal by bleeding patterns. Results: Average adjusted odds of reporting trouble sleeping were 29% higher in perimenopausal than in premenopausal women. The highest percentages of women in both menopausal groups reported trouble sleeping in the beginning or at the end of their cycle. After controlling for covariates, pregnanediol glucuronide level was associated with increased trouble sleeping in perimenopausal women and follicle-stimulating hormone level was associated with increased trouble sleeping in premenopausal women. Mood and vasomotor symptoms were the strongest and most consistent cocontributors to trouble sleeping. Conclusion: In this community-based sample of middle aged women, the most trouble sleeping was observed at the beginning and end of the menstrual cycle.

AB - Background: We analyzed data from a single menstrual cycle from 630 women, aged 43 to 53 years, in the Daily Hormone Study component of the Study of Women's Health Across the Nation to determine whether hormone levels are associated with trouble sleeping as women enter the menopausal transition. Methods: Women recorded whether they had trouble sleeping the previous night. Morning urine specimens were obtained for daily determinations of levels of luteinizing hormone, follicle-stimulating hormone, estradiol metabolites (ie, estrone conjugates), and the progesterone metabolite (pregnanediol glucuronide). Women were categorized as premenopausal or early perimenopausal by bleeding patterns. Results: Average adjusted odds of reporting trouble sleeping were 29% higher in perimenopausal than in premenopausal women. The highest percentages of women in both menopausal groups reported trouble sleeping in the beginning or at the end of their cycle. After controlling for covariates, pregnanediol glucuronide level was associated with increased trouble sleeping in perimenopausal women and follicle-stimulating hormone level was associated with increased trouble sleeping in premenopausal women. Mood and vasomotor symptoms were the strongest and most consistent cocontributors to trouble sleeping. Conclusion: In this community-based sample of middle aged women, the most trouble sleeping was observed at the beginning and end of the menstrual cycle.

UR - http://www.scopus.com/inward/record.url?scp=27844515978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844515978&partnerID=8YFLogxK

U2 - 10.1001/archinte.165.20.2370

DO - 10.1001/archinte.165.20.2370

M3 - Article

VL - 165

SP - 2370

EP - 2376

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 20

ER -